Guest: Louis Dron (CEO of Redwood AI)

The British Columbia government launched a pilot called Track and Trace, a two-year initiative led by Aidos Innovations, a nonprofit translational science institute developed at the University of British Columbia with support from law enforcement. “This new initiative will analyze the unique chemical fingerprints of illicit drugs,” says Victoria Police chief Fiona Wilson.

Key to the success of the pilot program is Vancouver-based Redwood AI, whose technology turns raw chemical testing into usable intelligence for police, border officials, and health agencies trying to keep pace with a drug supply that changes from week to week.

“Drug dealers do not publish the composition of the products they produce but we at Redwood AI can back calculate the method of production,” says Louis Dron, one of the founders of the Vancouver-based artificial intelligence company.

“Using our proprietary software and analytic solutions synthesis tests, we analyze more than one billion molecules and reactions and identify manufacturing pathways in seconds,” says Dron. The platform that the company created predicts and optimizes synthesis pathways across drug discovery and development, which enables law enforcement agencies to zero in on drug precursors, their source, and supply chain.

We invited Louis Dron, the CEO of Redwood AI, to join us for a Conversation That Matters about the convergence of advanced chemistry, AI, and addressing a missing link in the drug crisis in Canada.


Want to learn more about our guests?

Check out their episodes on our partnered program!

 
 
 
Next
Next

Ep. 604: Artificial Intelligence: Optimistic or Fear?